Molecular and Functional Characterization of Choline Transporter-Like Proteins in Esophageal Cancer Cells and Potential Therapeutic Targets.
10.4062/biomolther.2017.113
- Author:
Fumiaki NAGASHIMA
1
;
Ryohta NISHIYAMA
;
Beniko IWAO
;
Yuiko KAWAI
;
Chikanao ISHII
;
Tsuyoshi YAMANAKA
;
Hiroyuki UCHINO
;
Masato INAZU
Author Information
1. Departments of Anesthesiology, Tokyo Medical University, Tokyo 160-0023, Japan.
- Publication Type:Original Article
- Keywords:
Choline;
Transporter;
Esophageal cancer;
Apoptotic cell death;
Caspase-3/7
- MeSH:
Cell Death;
Cell Line;
Cell Membrane;
Cell Survival;
Choline Deficiency;
Choline*;
DNA Methylation;
Esophageal Neoplasms*;
Humans;
Mitochondria;
RNA, Messenger;
S-Adenosylmethionine
- From:Biomolecules & Therapeutics
2018;26(4):399-408
- CountryRepublic of Korea
- Language:English
-
Abstract:
In this study, we examined the molecular and functional characterization of choline uptake in the human esophageal cancer cells. In addition, we examined the influence of various drugs on the transport of [3H]choline, and explored the possible correlation between the inhibition of choline uptake and apoptotic cell death. We found that both choline transporter-like protein 1 (CTL1) and CTL2 mRNAs and proteins were highly expressed in esophageal cancer cell lines (KYSE series). CTL1 and CTL2 were located in the plasma membrane and mitochondria, respectively. Choline uptake was saturable and mediated by a single transport system, which is both Na+-independent and pH-dependent. Choline uptake and cell viability were inhibited by various cationic drugs. Furthermore, a correlation analysis of the potencies of 47 drugs for the inhibition of choline uptake and cell viability showed a strong correlation. Choline uptake inhibitors and choline deficiency each inhibited cell viability and increased caspase-3/7 activity. We conclude that extracellular choline is mainly transported via a CTL1. The functional inhibition of CTL1 by cationic drugs could promote apoptotic cell death. Furthermore, CTL2 may be involved in choline uptake in mitochondria, which is the rate-limiting step in S-adenosylmethionine (SAM) synthesis and DNA methylation. Identification of this CTL1- and CTL2-mediated choline transport system provides a potential new target for esophageal cancer therapy.
